PHARMACOGENOMICS LINK RS11615 OF ERCC1 TO CISPLATIN-INDUCED OTOTOXICITY

被引:0
|
作者
Zehnhoff-Dinnesen, A. Am [1 ]
Deuster, D. [1 ]
Malath, I. [2 ]
Eveslage, M. [3 ]
Ciarimboli, G. [4 ]
Langer, T. [5 ]
Zolk, O. [6 ]
Juergens, H. [2 ]
Lanvers-Kaminsky, C. [2 ]
机构
[1] Univ Hosp Munster, Clin Phoniatr & Pedaudiol, Munster, Germany
[2] Univ Hosp Munster, Dept Pediat Hematol & Oncol, Childrens Hosp, Munster, Germany
[3] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany
[4] Univ Hosp Munster, Expt Nephrol Dept Internal Med D, Munster, Germany
[5] Univ Hosp Erlangen, Dept Hematol Oncol Cell Therapy, Hosp Children & Adolescents, Erlangen, Germany
[6] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:164 / 164
页数:1
相关论文
共 50 条
  • [41] Genetic variants associated with cisplatin-induced ototoxicity
    Oldenburg, Jan
    Fossa, Sophie D.
    Ikdahl, Tone
    PHARMACOGENOMICS, 2008, 9 (10) : 1521 - 1530
  • [42] An integrated view of cisplatin-induced nephrotoxicity and ototoxicity
    Karasawa, Takatoshi
    Steyger, Peter S.
    TOXICOLOGY LETTERS, 2015, 237 (03) : 219 - 227
  • [43] The protective effect of astaxanthin on cisplatin-induced ototoxicity
    Terzi, Suat
    Ozgur, Abdulkadir
    Celiker, Metin
    Mercantepe, Tolga
    Yilmaz, Adnan
    Tumkaya, Levent
    Kaya, Seyma
    Demir, Emine
    Dursun, Engin
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 30 (03): : 315 - 321
  • [44] Oxytocin as a protective agent in cisplatin-induced ototoxicity
    Bilmez, Zekiye Eda Bekmez
    Aydin, Sedat
    Sanli, Arif
    Altintoprak, Niyazi
    Demir, Mehmet Gokhan
    Erdogan, Banu Atalay
    Kosemihal, Ebru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (04) : 875 - 879
  • [45] Circadian vulnerability of cisplatin-induced ototoxicity in the cochlea
    Tserga, Evangelia
    Moreno-Paublete, Rocio
    Sarlus, Heela
    Bjorn, Erik
    Guimaraes, Eduardo
    Goritz, Christian
    Cederroth, Christopher R.
    Canlon, Barbara
    FASEB JOURNAL, 2020, 34 (10): : 13978 - 13992
  • [46] Cisplatin-induced Ototoxicity in Children With Solid Tumor
    Wei, Meng
    Yuan, Xiaojun
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (02) : E97 - E100
  • [47] The effectiveness of eugenol against cisplatin-induced ototoxicity
    Sakat, Muhammed Sedat
    Kilic, Korhan
    Akdemir, Fazile Nur Ekinci
    Yildirim, Serkan
    Eser, Gizem
    Kiziltunc, Ahmet
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2019, 85 (06) : 766 - 773
  • [48] Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
    Ko, Jen-Chung
    Su, Ying-Jhen
    Lin, Szu-Ting
    Jhan, Jhih-Yuan
    Ciou, Shih-Ci
    Cheng, Chao-Min
    Chiu, Yu-Fan
    Kuo, Ya-Hsun
    Tsai, Min-Shao
    Lin, Yun-Wei
    LUNG CANCER, 2010, 69 (02) : 155 - 164
  • [49] Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity
    Sofia Waissbluth
    Pezhman Salehi
    Xinying He
    Sam J. Daniel
    European Archives of Oto-Rhino-Laryngology, 2013, 270 : 1597 - 1605
  • [50] Incidence and risk factors of cisplatin-induced ototoxicity
    Ignacio Benito-Orejas, Jose
    Sanchez-Martinez, Ana
    Jose Tavarez-Rodriguez, Juan
    Morais-Perez, Dario
    Soto Prado-Otero, Diego
    Fe Munoz-Moreno, Maria
    REVISTA ORL, 2021, 12 (03) : 217 - 230